US 10220093
Long-acting semi-solid lipid formulations
granted A61KA61K31/445A61K47/14
Quick answer
US patent 10220093 (Long-acting semi-solid lipid formulations) held by MIRA PHARMA CORPORATION expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MIRA PHARMA CORPORATION
- Grant date
- Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/445, A61K47/14, A61K9/0014, A61K9/0019